Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injections of PG-102 (MG12) in Healthy Adult and Obesity Participants. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of subcutaneous PG-102 (MG12) in healthy and overweight adults; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• PG-102(MG12) (MG12)

Snippet

Sponsor: ProGen. Co., Ltd. | Conditions: Healthy, Overweight | Phase 1 | Status: COMPLETED